Can leukocyte telomere shortening be a possible biomarker to track Huntington's disease progression?
Neural Regen Res
.
2019 Oct;14(10):1709-1710.
doi: 10.4103/1673-5374.257522.
Authors
Elide Mantuano
1
,
Martina Peconi
1
,
Daniela Scarabino
2
Affiliations
1
CNR Institute of Translational Pharmacology, Rome, Italy.
2
CNR Institute of Molecular Biology and Pathology, Rome, Italy.
PMID:
31169183
PMCID:
PMC6585568
DOI:
10.4103/1673-5374.257522
No abstract available